Purpose. Results of a study to determine the number of interventions unrelated to anticoagulation made in a pharmacist-managed anticoagulation clinic are presented.
D
espite new anticoagulation medications being brought to market, warfarin maintains a vital role in today's anticoagulation therapy. The continued use of warfarin results in the ongoing need for healthcare professionals skilled in anticoagulation management. Patients are currently referred to pharmacist-managed anticoagulation clinics as a mode of anticoagulation therapy management. Pharmacists have frequent interaction, weekly or more at times, with patients in this setting, allowing them to identify health-related problems and to make interventions outside of anticoagulation management.
Multiple studies have been published investigating outcomes directly related to anticoagulation therapy managed by pharmacists. Patients who participated in a pharmacistmanaged anticoagulation clinic had improved anticoagulation control or a greater time within the target range for the International Normalized Ratio (INR) when compared with usual care managed by a physician. [1] [2] [3] Pharmacists also have decreased time to followup in response to an INR value outside the target range. [3] [4] [5] Saokaew and colleagues 6 conducted a systematic review and meta-analysis investigating the effects of pharmacist-participated warfarin therapy management, which was shown to significantly reduce bleeding events by 50% when compared to usual care. Additional studies also showed a decrease in hemorrhages as well as thromboembolic events. [7] [8] [9] Anticoagulation clinics managed by pharmacists resulted in decreased hospital admissions related to warfarin 1, 7, 8, [10] [11] [12] as well as decreased hospital length of stay. 7, 8, [11] [12] [13] Pharmacistmanaged anticoagulation clinics also increase patients' knowledge and adherence to therapy, 14, 15 decrease drug interactions, 16 and increase or have positive patient and physician satisfaction. [17] [18] [19] Overall, patients participating in pharmacist-managed anticoagulation clinics had improved outcomes related to anticoagulation management and adverse effects.
Although there is considerable literature describing the benefits of anticoagulation therapy management and its related outcomes for patients in pharmacist-managed anticoagulation clinics, literature gaps remain. Little to no data have been collected and published that investigates interventions pharmacists make outside of an anticoagulation clinic's primary purpose. Pharmacists have an opportunity to identify problems and make interventions in clinics beyond those directly related to the primary disease that concerns the clinic. If overlooked, these problems could negatively impact the patient's health and increase healthcare costs. Consistent interaction with a pharmacist can serve as a gateway to identify healthcare problems and to receive appropriate healthcare when necessary. Research describing the impact of pharmacists in a pharmacist-managed anticoagulation clinic on patients' overall health is necessary to quantify services pharmacists provide and promote pharmacists as providers.
This study aimed to determine the number of interventions unrelated to anticoagulation made in a pharmacist-managed anticoagulation clinic, the results of selected in- terventions, and the association of patient factors with the occurrence of an intervention.
Methods
A retrospective, single-center, cohort study was completed at an outpatient pharmacist-managed ambulatory anticoagulation clinic, which collaborates with the internal medicine practice at a 511 adult-bed community teaching hospital. At the time of this study, three pharmacists and seven postgraduate year 1 pharmacy residents rotated through the anticoagulation clinic. One pharmacist and one or two pharmacy residents staffed the clinic at a time, and appointments were scheduled during four half-days per week. The primary mode of conducting anticoagulation appointments was face-to-face, with a small fraction of patients managed via telephone encounters based on patient-specific need. Thirty physicians referred patients to the clinic for anticoagulation management during the study period.
Active patients between January 1, 2012, and November 30, 2013, were identified using the clinic's Microsoft Access database (Microsoft Corporation, Redmond, WA). Clinic pharmacists used this database to track patients, follow-up times, and quality measures. All patients at least 18 years old and attending at least one face-to-face appointment were included for data collection. All face-to-face patient encounters with a pharmacist documented in the electronic medical record (EMR) during the study period were analyzed for the presence of interventions unrelated to anticoagulation based on criteria developed for this study. Interventions unrelated to anticoagulation were defined as any action taken by a pharmacist regarding a patient's health management that was not related to that patient's anticoagulation management in any way. These interventions may fall outside of an anticoagulation clinic's protocols but were done for issues not related to the patient's anticoagulation management. A standardized template is used to document patient encounters, and it is clinic practice to document interventions unrelated to anticoagulation following the anticoagulation management plan.
Interventions unrelated to anticoagulation were classified according to the criteria described in detail in the appendix. These criteria were developed by the investigators to be used for purposes of this study and were classified into 6 major categories and 33 subcategories. For 17 of these 33 subcategories, the result of the pharmacist intervention was determined and categorized as described in the appendix. Interventions for which measurable results were not possible were not included in this analysis. Predetermined patient factors were collected for all patients and analyzed for association with the occurrence of an intervention. Patient factors included age, number of medications, number of health problems, number of physician visits, physician referral source, and insurance status. Age, number of medications, and physician referral source were recorded as the value at the time of the first appointment with a pharmacist in the anticoagulation clinic within the study timeframe. The number of medications included all prescription medications, nonprescription medications, vitamins, and herbal supplements documented in the patient's EMR. The number of health problems and insurance status were recorded as the value at the time of data collection.
Only chronic health problems documented in the patient's EMR problem list were counted. Acute illnesses were excluded, and duplicate entries were counted only once. Physician visits were counted and recorded as any primary care visit within one year prior to seeing a pharmacist in the anticoagulation clinic. It was only possible to count physician visits for patients referred by internal medicine physicians because of medical record access.
A waiver of informed consent was requested because of the study's retrospective design and minimal risk to included subjects. This study was approved by the institutional review board at the investigators' institution.
Primary outcomes included the total number of interventions unrelated to anticoagulation along with the total number and percentage of interventions made in each major category of the study criteria. In addition, the total number and percentage of patients having at least one intervention and the percentages of patients having 0, 1-3, 4-6, 7-9, 10-12, 13-15, and >15 interventions were determined. The total number and percentage of each result for selected interventions performed by pharmacists were included in the secondary outcomes. In addition, the association of patient factors with the occurrence of an intervention was calculated.
Descriptive statistics were used for all outcomes. Relative risk (RR) was calculated describing patient factor association with the occurrence of an intervention. Patient factors are described and compared as follows: age of ≥60 years relative to <60 years, >10 medications and 5-10 medications relative to <5 medications, at least five health problems relative to fewer than five health problems, at least two physician visits relative to fewer than two physician visits, internal medicine physician referral relative to noninternal medicine referral, and insured patients relative to uninsured patients. Statistics were calculated using Microsoft Excel for Mac 2011 (version 14.4.5, Microsoft Corporation).
Results
A total of 270 patients were identified and screened for inclusion in the study. After screening, 268 patients were included for analysis and identification of interventions unrelated to anticoagulation. Two patients were excluded because they were <18 years old during the study period. A total of 5846 patient encounters during the study period were reviewed. Patient characteristics are described in Table 1 . The mean age of patients active in the anticoagulation clinic was 58.2 years. Patients had a mean of 10.3 medications and 10.0 health problems, suggesting that patients active in the anticoagulation clinic had a significant burden of medical illness. Patients attended a mean of 2.1 primary care visits within 1 year prior to seeing a pharmacist in the anticoagulation clinic.
A total of 2222 interventions unrelated to anticoagulation during the study period were identified. Among the included 268 patients, 252 had at least 1 intervention unrelated to anticoagulation. The number of interventions per patient is described as follows: 73.1% (196) of patients had ≥4 interventions, 32.5% (87) of patients had ≥10 interventions, and 13.8% (37) of patients had >15 interventions. The total number and percentage of interventions made in each major study criterion category along with those in each subcategory are shown in Table 2 . The largest proportion of interventions made, 1591 interventions (71.6%), was classified under "reconcile medications." The second and third highest proportions of interventions were classified under "promote continuity of care" and "health assessment and triage" and made up 252 interventions (11.3%) and 206 interventions (9.3%), respectively. Of the interventions classified under "promote continuity of care," pharmacists identified pertinent medical information and ensured that the patient's physician was notified 112 times. Interventions performed by a pharmacist in the "health assessment and triage" category included 58 patients advised to follow up with their primary physician, 37 patients seen by a physician in the anticoagulation clinic immediately, and 30 patients referred to the emergency department. The remaining 7.8% of interventions were classified under "acquire necessary diagnostics," "modify therapy," and "drug information and counseling." For the subcategories of criteria for which an intervention result was determined, the number and percentages of each result are shown in Table 3 . These specific intervention results are reported combining the total number of interventions under each major criterion category. Interventions classified under "promote continuity of care" and "health assessment and triage" resulted in 44.6% and 55.2% of patients, respectively, receiving additional treatment. These treatments ranged from the addition of medications to hospital admission. For interventions performed under "reconcile medications," the accuracy of whether patients were taking their medication correctly along with the accuracy of the medication list was determined. Patients were taking a medication correctly for 88.7% of interventions, while 6.7% of these interventions consisted of the patient taking a medication incorrectly. The remaining 4.6% of intervention results were undetermined. This represents 107 instances when pharmacists intervened on patients taking their medication incorrectly and an additional 74 instances where a patient could potentially be taking his or her medications incorrectly. When looking at the anticoagulation clinic's medication list accuracy, the medication list was incorrect for 89.4% of interventions. These inaccuracies could range from an obsolete antibiotic course to an inaccuracy with a serious risk of health consequences, such as an incorrect antiarrhythmic agent dose. The significance of medication list inaccuracies was not determined. Interventions in which the pharmacist facilitated acquiring diagnostics primarily consisted of orders for laboratory studies. The results of the diagnostics were found to be abnormal in 13.3% of interventions. Of the interventions in which a pharmacist recommended modification of a patient's drug therapy, 66.7% of recommendations were accepted.
Two of the six evaluated patient factors were found to be associated with an increased likelihood of having an intervention. Patients with >10 medications had an increased likelihood of having an intervention relative to patients with <5 medications (RR, 1.17; 95% confidence interval [CI], 1.02-1.33]), and patients seeing a primary physician at least two times one year prior to their first appointment with a pharmacist in the clinic had an increased likelihood of having an intervention relative to patients seeing a primary physician fewer than two times (RR, 1.12; 95% CI, 1.03-1.22). A statistically significant difference in the likelihood of having an intervention was not found for other patient factors including 5-10 medications, number of health problems, referring physician, insurance status, and age. All results describing the association of patient factors with having an intervention are shown in Table 4 .
Discussion
This study's unique approach to analyzing the patient benefits of participating in a pharmacist-managed anticoagulation clinic gave insight into the various services pharmacists are able to provide patients who participate in such clinics.
In addition to improving anticoagulation management, pharmacists can contribute to the overall care of a patient. The substantial number of interventions unrelated to anticoagulation promotes pharmacists being recognized as providers. A large proportion of interventions were related to medication reconciliation and clarifying medication discrepancies. Furthermore, a large proportion of discrepancies were related to inaccuracies in the medication list. The medication list used by the anticoagulation clinic is not only used by the pharmacists but is also used by internal medicine physicians and for medication reconciliation upon hospital admission. Although pharmacists corrected many inaccuracies in the medication list, they also educated a large number of patients who were taking their medication incorrectly. The high number of medication discrepancies identified emphasizes the importance of conducting medication reconciliation as a standard of care at all ambulatory care visits. It also supports the creation of and participation in pharmacist-managed transition-of-care clinics. Pharmacist involvement in clarifying medication discrepancies and improving patient adherence may reduce the risk of medication-related errors. The interventions identified under "promote continuity of care" and "health assessment and triage" a Number of physician visits could only be determined for internal medicine referral patients (n = 159).
truly reflect the impact a pharmacist can make on patient care. These interventions included a total of 458 instances where a pharmacist identified a health-related problem and facilitated the patient receiving appropriate care. Without a pharmacist being an integral part of the patient's healthcare team, these 458 instances may have gone unnoticed or care may have been delayed. These data support regular involvement of a pharmacist in patient care and demonstrate that interaction with a pharmacist can provide benefits beyond the primary purpose of a pharmacist-managed outpatient clinic. The information obtained from this study supports the contributions pharmacists make to patient care. It promotes the expansion of pharmacist-managed clinics and making them an integral part of the standard of patient care.
Because recognizing pharmacists as providers and having patients regularly participate in pharmacistmanaged clinics would involve reimbursement for pharmacist services, knowledge of the type of patients who may benefit would be helpful. This study found a patient's number of medications and number of physician visits one year prior to seeing a pharmacist to be significantly associated with the likelihood of having an intervention. Both of these patient factors suggest that these patients were in poorer health than other patients and may have an increased benefit from seeing a pharmacist regularly. Other patient factors were not found to be significant, but it is possible that not enough patients were included to find a difference for the other patient factors analyzed.
Because it was a retrospective cohort, this study inherently had limitations based on documentation. A combination of 10 pharmacy residents and pharmacists rotating through the anticoagulation clinic may introduce multiple styles of practice and documentation practices. In addition, interventions unrelated to anticoagulation must be deemed important by the pharmacist for them to be documented in the EMR. However, a standardized template reduces variance in encounter notes, and it is the anticoagulation clinic's practice to document interventions outside of anticoagulation management in a specific location of the template. This study was also limited in that its criteria were developed by the investigators for purposes of this study and have not been validated. A literature search was completed to identify a validated tool applicable to identifying interventions for this study; however, an appropriate tool was not found. Because no research has looked at interventions outside S86 AM J HEALTH-SYST PHARM | VOLUME 73 | SUPPLEMENT 3 | JUNE 1, 2016 of a clinic's primary purpose, it was necessary to develop the study criteria. Further research conducted to validate the study criteria should help develop a simple tool to track interventions pharmacists make outside of a clinic's primary purpose. Assigning significance levels to interventions made, especially medication discrepancies, would have added further insight into the impact of pharmacists in this healthcare setting. However, investigators did not identify a tool to objectively collect significance data. It might be beneficial to include additional factors to analyze for an association with having an intervention. More specifically, looking at the association of interventions relative to the time of hospital discharge or duration of warfarin therapy would be useful. This would provide insight into the benefit of pharmacist-managed transition-of-care clinics by isolating a time in patients' healthcare where multiple changes are likely to occur. Finally, interventions were identified only in patients who attended face-to-face appointments with a pharmacist. Because a number of pharmacist clinics conduct appointments via telephone, future studies comparing pharmacist interventions between these modes of patient encounters may be beneficial.
Conclusion
Pharmacists in an anticoagulation clinic made 2222 interventions unrelated to anticoagulation therapy, with most clinic patients having at least one such intervention made on their behalf. The total number of medications being taken and the number of physician visits were significantly associated with an intervention taking place.
Disclosures
Appendix-Criteria for pharmacist interventions and results
I. Promote continuity of care
A. Pharmacist obtains patient's medical records (pharmacist identifies need and obtains consent from patient to obtain medical records from outside facility); intervention result not evaluated. B. Pharmacist facilitates medication refill (pharmacist contacts prescriber or prescriber's representative for prescription refill); intervention result not evaluated. C. Pharmacist educates patient about appropriate follow-up with another healthcare provider (education documented that patient was informed about appropriate follow-up); intervention result not evaluated. D. Pharmacist schedules appointment with another healthcare
